[go: up one dir, main page]

AU3419499A - Method and nucleic acid compound for breaking down nucleic acid molecules synthesized (in vitro) - Google Patents

Method and nucleic acid compound for breaking down nucleic acid molecules synthesized (in vitro)

Info

Publication number
AU3419499A
AU3419499A AU34194/99A AU3419499A AU3419499A AU 3419499 A AU3419499 A AU 3419499A AU 34194/99 A AU34194/99 A AU 34194/99A AU 3419499 A AU3419499 A AU 3419499A AU 3419499 A AU3419499 A AU 3419499A
Authority
AU
Australia
Prior art keywords
nucleic acid
vitro
breaking down
molecules synthesized
acid molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34194/99A
Inventor
Robert-Mathias Leiser
Lutz Plobner
Jochen Temper
Sergei Zavriev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mira Diagnostica GmbH
Original Assignee
Mira Diagnostica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mira Diagnostica GmbH filed Critical Mira Diagnostica GmbH
Publication of AU3419499A publication Critical patent/AU3419499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6848Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
AU34194/99A 1998-03-27 1999-03-26 Method and nucleic acid compound for breaking down nucleic acid molecules synthesized (in vitro) Abandoned AU3419499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19813689 1998-03-27
DE19813689 1998-03-27
PCT/EP1999/002248 WO1999050447A1 (en) 1998-03-27 1999-03-26 METHOD AND NUCLEIC ACID COMPOUND FOR BREAKING DOWN NUCLEIC ACID MOLECULES SYNTHESIZED $i(IN VITRO)

Publications (1)

Publication Number Publication Date
AU3419499A true AU3419499A (en) 1999-10-18

Family

ID=7862642

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34194/99A Abandoned AU3419499A (en) 1998-03-27 1999-03-26 Method and nucleic acid compound for breaking down nucleic acid molecules synthesized (in vitro)

Country Status (2)

Country Link
AU (1) AU3419499A (en)
WO (1) WO1999050447A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1041159A3 (en) * 1999-03-26 2000-10-25 MIRA Diagnostika GmbH Method, oligonucleotides suitable for the degradation of in vitro synthesized nucleic acid molecules
US7668658B2 (en) 1999-10-13 2010-02-23 Sequenom, Inc. Methods for generating databases and databases for identifying polymorphic genetic markers
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
WO2003093296A2 (en) 2002-05-03 2003-11-13 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof, and related methods
CN101233240A (en) 2004-03-26 2008-07-30 斯昆诺有限公司 Base-specific cleavage of methylation-specific amplification products combined with mass analysis
US7608394B2 (en) 2004-03-26 2009-10-27 Sequenom, Inc. Methods and compositions for phenotype identification based on nucleic acid methylation
US20110003700A1 (en) * 2007-12-20 2011-01-06 Human Genetic Signatures Pty Ltd. Elimination of contaminants associated with nucleic acid amplification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD265429A1 (en) * 1987-09-30 1989-03-01 Adl Inst Phytopathologie PROCESS FOR THE NONTRADIOACTIVE MARKING OF POLYNUCLEOTIDES
US5683896A (en) * 1989-06-01 1997-11-04 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
EP0540693B1 (en) * 1990-07-24 1999-01-20 F. Hoffmann-La Roche Ag THE REDUCTION OF NON-SPECIFIC AMPLIFICATION DURING $i(IN VITRO) NUCLEIC ACID AMPLIFICATION USING MODIFIED NUCLEIC ACID BASES
CA2122203C (en) * 1993-05-11 2001-12-18 Melinda S. Fraiser Decontamination of nucleic acid amplification reactions
US6190865B1 (en) * 1995-09-27 2001-02-20 Epicentre Technologies Corporation Method for characterizing nucleic acid molecules

Also Published As

Publication number Publication date
WO1999050447A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
AU5493201A (en) Method for introduction of molecules into cells
AU8909998A (en) Methods and compositions for cloning nucleic acid molecules
AU3027699A (en) Nucleic acid analysis method
AU3699899A (en) Method for conducting the synthesis of nucleic acid molecules
AU3196099A (en) Systematic identification of essential genes by (in vitro) transposon mutagenesis
EP0933132B8 (en) Nucleic Acid Extraction Apparatus
AU5338099A (en) Method of advertising
AU3199699A (en) Modified nucleotides and methods useful for nucleic acid sequencing
AU4579399A (en) Fluoxetine process from benzoylpropionic acid
AU5763900A (en) Methods of enriching for and identifying polymorphisms
AU2680100A (en) Method and apparatus for nucleic acid strand separation
AU7051500A (en) Method of and system for displaying cards
AU6610200A (en) Method and system for process design
AUPP278698A0 (en) Method of cell nuclei segmentation
AU4848099A (en) Merchant analysis support method
AU4655599A (en) Method of preparing objects containing dna
AU3419499A (en) Method and nucleic acid compound for breaking down nucleic acid molecules synthesized (in vitro)
EP1093002B8 (en) Microscope and method for changing microscope objectives
AU5901199A (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
AU3981799A (en) Method for identifying genes
AU2509799A (en) Method for isolating short and long-chain nucleic acids
AU1718101A (en) Reagent and method for delivery of molecules into cells
AU5575998A (en) Process for producing benzylsuccinic acid derivatives
AU8694598A (en) Methods for quantifying nucleic acid molecules
AU3628999A (en) Method for quantitating specific gene sequence and quantitating reagent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase